Bessemer Group Inc. trimmed its position in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 2.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,805,630 shares of the exchange traded fund’s stock after selling 47,602 shares during the quarter. Bessemer Group Inc.’s holdings in SPDR S&P Biotech ETF were worth $230,633,000 as of its most recent SEC filing.
Other hedge funds have also made changes to their positions in the company. Financial Life Planners acquired a new stake in shares of SPDR S&P Biotech ETF during the 1st quarter worth approximately $27,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter valued at approximately $27,000. Intesa Sanpaolo Wealth Management acquired a new position in SPDR S&P Biotech ETF in the fourth quarter valued at approximately $30,000. SHP Wealth Management acquired a new position in SPDR S&P Biotech ETF in the fourth quarter valued at approximately $31,000. Finally, Legacy Wealth Managment LLC ID purchased a new position in SPDR S&P Biotech ETF in the fourth quarter worth approximately $32,000.
SPDR S&P Biotech ETF Stock Performance
Shares of SPDR S&P Biotech ETF stock opened at $152.00 on Friday. The stock has a 50 day moving average of $142.06 and a 200 day moving average of $132.23. The firm has a market capitalization of $10.34 billion, a price-to-earnings ratio of 11.47 and a beta of 0.82. SPDR S&P Biotech ETF has a fifty-two week low of $84.39 and a fifty-two week high of $165.71.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Recommended Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
